Recombinant activated factor VII in chronic liver diseases: Should we be afraid of thromboembolic events?
نویسندگان
چکیده
منابع مشابه
Should We Be Afraid of Friedman’s Rule?
Should one think of zero nominal interest rates as an undesirable liquidity trap or as the desirable Friedman rule? I use three different frameworks to discuss this issue. First, I restate H. L. Cole and N. Kocherlakota’s (1998, Fed. Res. Bank Minn. Quart. Rev., Spring, 2–10) analysis of Friedman’s rule: short run increases in the money stock—whether through issuing spending coupons, open marke...
متن کاملShould we be afraid of the dark
We exploit a unique natural experiment – recent restrictions of dark trading in Canada – and proprietary trade-level data to analyze the effects of dark trading. Disaggregating two types of dark trading, we find that dark limit order markets are beneficial to market quality, reducing quoted, effective and realized spreads and increasing informational efficiency. In contrast, dark midpoint cross...
متن کاملSafe food: should we be afraid?
comment on Schmidt CW: Safe food: an all-consuming issue. Environ Health Perspect 107:A144-A149 (1999).
متن کاملProphylactic Activated Recombinant Factor VII in Liver Resection and Liver Transplantation: Systematic Review and Meta-Analysis
BACKGROUND AND AIM Intraoperative blood loss is a frequent complication of hepatic resection and orthotopic liver transplantation. Recombinant activated coagulation factor VII (rFVIIa) is a coagulation protein that induces hemostasis by directly activating factor X. There is no clear information about the prophylactic value of rFVIIa in hepatobiliary surgery, specifically in liver resection and...
متن کاملThe role of recombinant activated factor VII in cardiac surgery
Recombinant factor VIIa may reduce surgical blood loss and transfusion of blood products in cardiac surgery. However, the true risks of its use in this setting remains to be elucidated, especially when it is administered with other potent pro-haemostatic agents. We reviewed the recent literature on this topic and suggest that the off label use of recombinant factor VIIa is likely to continue. I...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Hepatology
سال: 2011
ISSN: 0168-8278
DOI: 10.1016/j.jhep.2011.01.043